05:41 PM EDT, 10/15/2024 (MT Newswires) -- Mark A Goldsmith, Director, President and Chief Executive Officer, on October 11, 2024, sold 30,000 shares in Revolution Medicines ( RVMD ) for $1,510,773. Following the Form 4 filing with the SEC, Goldsmith has control over a total of 816,622 shares of the company, with 300,170 shares held directly and 516,452 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1628171/000161071724000508/xslF345X05/form4.xml

Price: 47.15, Change: -1.84, Percent Change: -3.76